Pages that link to "Q42662159"
Jump to navigation
Jump to search
The following pages link to A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease (Q42662159):
Displaying 17 items.
- Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection (Q26849521) (← links)
- Rapid progressive long esophageal stricture caused by gastroesophageal reflux disease after pylorus-preserving pancreatoduodenectomy (Q35993040) (← links)
- Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure (Q36319536) (← links)
- Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. (Q36542670) (← links)
- Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults (Q37032564) (← links)
- A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD). (Q37160360) (← links)
- Proton pump inhibitors: an update of their clinical use and pharmacokinetics (Q37235086) (← links)
- Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. (Q37299839) (← links)
- Esomeprazole: a proton pump inhibitor (Q37390644) (← links)
- Insights into the future of gastric acid suppression (Q37588492) (← links)
- Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs? (Q37815295) (← links)
- Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole (Q42170103) (← links)
- Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults. (Q46830968) (← links)
- The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits (Q46878264) (← links)
- Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial (Q46907607) (← links)
- The role of pH in symptomatic relief and effective treatment of gastroesophageal reflux disease (Q49860893) (← links)
- Nocturnal acid breakthrough on proton pump inhibitor therapy: to treat or not to treat (Q82387739) (← links)